Device innovation is driving improvement in stroke treatment outcomes

July 27, 2015, Society of NeuroInterventional Surgery

In the last decade, Intra-Arterial (IA) stroke therapy (a technique in which thrombolytic agents and devices are passed through the arteries directly to the clot site) has gained notable momentum as an effective and safe treatment option for patients. Two new studies released today at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, further reinforce the value and progress of IA treatment with conclusions that the innovative new devices that facilitate this approach are reducing treatment times, improving outcomes and decreasing mortality rates.

Since Stent Retrievers - the latest evolution of devices for IA - became available in 2012, no comparative analysis with pre-retriever devices has been conducted to determine differences in utilization or clinical outcomes. In the Trends and Outcomes of Mechanical Thrombectomy in Patients with Acute Ischemic Stroke: A Review of National In-Patient Database, joint investigators, Drs. Srikanth Boddu and Ning Lin, at New York Presbyterian Hospital and Weill Cornell Medical Center in New York, New York, used the Nationwide Inpatient Sample (NIS) database provided by the Agency for Healthcare Research and Quality (AHRQ) to analyze outcomes across three generations of devices: 2006-2007 (Post-MERCI); 2008-2011 (Post-Penumbra); and 2012 (Stent Retrievers).

Results showed that while the number of stroke cases climbed across these three time periods, from 723,327 to 738,490, the rate of deaths decreased with newer devices. In 2012, Stent Retrievers were associated with a mortality rate of 17.1 percent vs. pre-retriever devices in both 2008-2011 (19.3 percent) and 2006-2007 (25 percent). Additionally, the age-specific mortality following stroke intervention decreased with newer devices for patients ? 80 and 65-79 years of age: 2012 (20 and 14.9 percent, respectively) compared to 2008-2011 (25.8 and 20.5 percent, respectively) and 2006-2007 (26.3 and 30.2 percent, respectively). These findings are significant as they prove that older patients can in fact benefit from IA therapy and that age, alone, is not an exclusion criteria for interventional treatment.

"It is clear that the introduction of Stent Retrievers for has been a significant game changer. Not only have these tools provided practitioners with new approaches to treatment," said Dr. Srikanth Boddu, lead investigator and interventional neuroradiologist at the Weill Cornell Brain and Spine Center in New York, New York, "but we have also proven that innovation is worth the investment. With treatment advances, we are seeing increasing numbers of patients survive stroke."

In a second study, Implementation of New Technological Advances of Endovascular Treatment in Acute Ischemic Stroke Provides Overall Improvement in Procedural Times conducted at the Swedish Medical Center in Englewood, Colorado, the usefulness and performance afforded by evolving devices were again the focus as investigators sought to understand if newer tools were associated with better outcomes and shorter procedural times. A data analysis was conducted across 6 prospective and retrospective endovascular treatment trials, with various evolutions of the Penumbra Aspiration System being used as the primary therapy. Out of a pool of 932 subjects, study results showed that the newer and larger Penumbra catheters provided a faster and more efficient method for treating . In turn, when considering variables including age, baseline National Institutes of Health Stroke Scale (NIHSS) score (which assesses stroke severity), and post-treatment status of restoration of blood flow, shorter procedural times were a significant predictor of better at 90 days, as measured by the modified Rankin Scale (mRS), a standard tool used to indicate level of independence following a stroke.

Dr. Donald Frei, lead author of the study, president of the Society of NeuroInterventional Surgery (SNIS) and neurointerventionalist at Swedish Medical Center, echoed the optimistic sentiment espoused by Dr. Boddu. "As each new generation of devices provides improved tools for our treatment arsenal, we are able to adjust our approach to maximize efficiencies and results for our patients. Time is the most important factor when treating a , so it is incumbent upon all of us to use every tool at our disposal to achieve fast and effective treatment," Dr. Frei said. "Thankfully, each generation of new devices has proven to reduce procedure time, which raises the chance of a successful operation."

Explore further: New guidelines recommend brain stents to fight strokes in certain patients

Related Stories

New guidelines recommend brain stents to fight strokes in certain patients

July 2, 2015
New devices called stent retrievers are enabling physicians to benefit selected patients who suffer strokes caused by blood clots. The devices effectively stop strokes in their tracks.

Clot-removal devices now recommended for some stroke patients

June 29, 2015
For the first time, the American Heart Association/American Stroke Association recommends using a stent retrieval device to remove blood clots in select stroke patients who have clots obstructing the large arteries supplying ...

New stent devices can limit stroke damage, says neurosurgeon

March 27, 2015
Elizabeth Celli was experiencing a moderate-to-severe stroke when she arrived at Loyola University Medical Center's Emergency Department.

New study 'game-changer' for stroke treatment worldwide

February 11, 2015
A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.

Emergency transport times for stroke patients still in need of improvement

July 27, 2015
Despite efforts to close the time gap between symptom onset and stroke treatment - including improvements in public education, 911 dispatch operations, pre-hospital detection and triage, hospital stroke system development, ...

Stroke patients experience superior outcomes with intra-arterial treatment vs. tPA

December 17, 2014
Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including ...

Recommended for you

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

Stroke prevention drug combo shows promise, study says

May 16, 2018
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.